IMUX
Immunic Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.17
-0.20 ▼ -14.60%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$1.16
-0.01 ▼ -0.83%
| Index | - | P/E | - | EPS (ttm) | -0.75 | Insider Own | 1.31% | Shs Outstand | 0.13B | Perf Week | -4.88% |
| Market Cap | 0.15B | Forward P/E | - | EPS next Y | -2.37% | Insider Trans | - | Shs Float | 0.13B | Perf Month | 57.62% |
| Enterprise Value | 0.14B | PEG | - | EPS next Q | -0.09 | Inst Own | 58.49% | Short Float | 5.89% | Perf Quarter | 71.3% |
| Income | -0.10B | P/S | - | EPS this Y | 46.17% | Inst Trans | 24.69% | Short Ratio | 2.21 | Perf Half Y | 37.32% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 33.48% | ROA | -299.36% | Short Interest | 7.58M | Perf YTD | 119.22% |
| Book/sh | -0.06 | P/C | 9.86 | EPS past 3/5Y | 45.16% 25.98% | ROE | -1653.15% | 52W High | -22.52% ($1.51) | Perf Year | 4.46% |
| Cash/sh | 0.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 131.13% ($0.51) | Perf 3Y | -30.36% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 27.87% | Gross Margin | - | Volatility(W/M) | 12.41% 12.98% | Perf 5Y | -92.8% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.12 | Perf 10Y | -99.66% |
| Dividend Ex-Date | - | Quick Ratio | 0.75 | EPS Q/Q | 42.59% | Profit Margin | - | RSI (14) | 57.84 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.75 | Sales Q/Q | - | SMA20 | 9.18% ($1.07) | Beta | 1.33 | Target Price | $4.57 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | 42.09% ($0.82) | Rel Volume | 1.47 | Prev Close | $1.37 |
| Employees | 92 | LT Debt/Eq | - | EPS/Sales Surpr. | -2.22% - | SMA200 | 44.86% ($0.81) | Avg Volume(3M) | 3.43M | Price | $1.17 |
| IPO | 2014/4/17 | Option/Short | Yes/Yes | Trades | 5622 | Volume | 5,055,802 | Change | -14.6% |
뉴스 로딩 중...